Raymond James Financial Services Advisors, Inc. Corcept Therapeutics Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 19, 2024	BUY	$22.21 - $34.48 $610,508 - $947,786	27,488 Added 54.86%	77,593 $2.52 Million
Q1 2024 Apr 22, 2024	BUY	$21.1 - $27.46 $1.06 Million - $1.38 Million	50,105 New	50,105 $1.26 Million

Others Institutions Holding CORT

# of Institutions

350

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

Black Rock Inc. New York, NY

16.5M
Shares

$915 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$553 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.27M
Shares

$457 Million
14.93% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.51M
Shares

$360 Million
0.48% of portfolio
Parallel Advisors, LLC

3.81M
Shares

$211 Million
4.22% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account